145 related articles for article (PubMed ID: 16404424)
21. Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome.
Iwai M; Kiyoi H; Ozeki K; Kinoshita T; Emi N; Ohno R; Naoe T
Leukemia; 2005 Aug; 19(8):1367-75. PubMed ID: 15902282
[TBL] [Abstract][Full Text] [Related]
22. Methylation analysis of the von Hippel-Lindau gene in acute myeloid leukaemia and myelodysplastic syndromes.
Benetatos L; Dasoula A; Syed N; Hatzimichael E; Crook T; Bourantas KL
Leukemia; 2008 Jun; 22(6):1293-5. PubMed ID: 18094722
[No Abstract] [Full Text] [Related]
23. Mutation of the WT1 gene in myelodysplastic syndrome and acute myeloid leukaemia post myelodysplastic syndrome.
Mori N; Okada M; Motoji T; Mizoguchi H
Br J Haematol; 1999 Jun; 105(3):844-5. PubMed ID: 10354161
[No Abstract] [Full Text] [Related]
24. Transcriptional down-regulation of the Wnt antagonist SFRP1 in haematopoietic cells of patients with different risk types of MDS.
Reins J; Mossner M; Neumann M; Platzbecker U; Schumann C; Thiel E; Hofmann WK
Leuk Res; 2010 Dec; 34(12):1610-6. PubMed ID: 20471677
[TBL] [Abstract][Full Text] [Related]
25. Mutations within the FLR exon of NF1 are rare in myelodysplastic syndromes and acute myelocytic leukemias.
Ludwig L; Janssen JW; Schulz AS; Bartram CR
Leukemia; 1993 Jul; 7(7):1058-60. PubMed ID: 8321021
[TBL] [Abstract][Full Text] [Related]
26. The cancer‑testis antigen NXF2 is activated by the hypomethylating agent decitabine in acute leukemia cells in vitro and in vivo.
Zhou J; Li Y; Yao Y; Wang L; Gao L; Gao X; Luo X; Li J; Jiang M; Zhou M; Wang L; Yu L
Mol Med Rep; 2013 Nov; 8(5):1549-55. PubMed ID: 24002123
[TBL] [Abstract][Full Text] [Related]
27. Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression.
Scott SA; Lakshimikuttysamma A; Sheridan DP; Sanche SE; Geyer CR; DeCoteau JF
Exp Hematol; 2007 Feb; 35(2):263-73. PubMed ID: 17258075
[TBL] [Abstract][Full Text] [Related]
28. DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia.
Shiba N; Taki T; Park MJ; Shimada A; Sotomatsu M; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Arakawa H; Hayashi Y
Br J Haematol; 2012 Feb; 156(3):413-4. PubMed ID: 21981547
[No Abstract] [Full Text] [Related]
29. [WHO classification of acute myeloid leukaemia (AML) and the myelodysplastic syndrome (MDS)].
Haferlach T; Schoch C
Dtsch Med Wochenschr; 2002 Mar; 127(9):447-50. PubMed ID: 11870559
[No Abstract] [Full Text] [Related]
30. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.
Georgiou G; Karali V; Zouvelou C; Kyriakou E; Dimou M; Chrisochoou S; Greka P; Dufexis D; Vervesou E; Dimitriadou E; Efthymiou A; Petrikkos L; Dima K; Lilakos K; Panayiotidis P
Br J Haematol; 2006 Aug; 134(3):302-6. PubMed ID: 16787503
[TBL] [Abstract][Full Text] [Related]
31. Meningioma 1 gene is differentially expressed in CD34 positive cells from bone marrow of patients with myelodysplastic syndromes with the highest expression in refractory anemia with excess of blasts and secondary acute myeloid leukemia.
Schroeder T; Czibere A; Zohren F; Aivado M; Gattermann N; Germing U; Haas R
Leuk Lymphoma; 2009 Jun; 50(6):1043-6. PubMed ID: 19391034
[No Abstract] [Full Text] [Related]
32. AML1 mutation and FLT3-internal tandem duplication in leukemia transformed from myelodysplastic syndrome.
Shimada A; Taketani T; Kikuchi A; Hanada R; Arakawa H; Kimura H; Chen Y; Hayashi Y
J Pediatr Hematol Oncol; 2007 Sep; 29(9):666-7. PubMed ID: 17805050
[No Abstract] [Full Text] [Related]
33. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki JR; Vincent PC; Clark SJ
Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
[TBL] [Abstract][Full Text] [Related]
34. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
36. Polymerase chain reaction analysis of allele frequency and loss at the Harvey ras locus in myeloid malignancies.
Ardern JC; Saunders MJ; Hyde K; Lawson R; Yin JA; Lucas GS
Leukemia; 1993 Feb; 7(2):258-62. PubMed ID: 8426479
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts.
Rethmeier A; Aggerholm A; Olesen LH; Juhl-Christensen C; Nyvold CG; Guldberg P; Hokland P
Br J Haematol; 2006 May; 133(3):276-83. PubMed ID: 16643429
[TBL] [Abstract][Full Text] [Related]
38. Methylation silencing of the Apaf-1 gene in acute leukemia.
Furukawa Y; Sutheesophon K; Wada T; Nishimura M; Saito Y; Ishii H; Furukawa Y
Mol Cancer Res; 2005 Jun; 3(6):325-34. PubMed ID: 15972851
[TBL] [Abstract][Full Text] [Related]
39. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD
Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543
[TBL] [Abstract][Full Text] [Related]
40. Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemia.
Stumpel DJ; Schneider P; van Roon EH; Pieters R; Stam RW
Eur J Cancer; 2013 Jan; 49(1):175-84. PubMed ID: 22921182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
